CALGARY, ALBERTA--(Marketwire - Oct. 22, 2009) - Alaris Royalty Corp. ("Alaris" or the "Corporation") (TSX:AD) is pleased to announce that the Alaris board of directors has closed the funding of $12,000,000 for LifeMark Health Limited Partnership ("LifeMark") in support of LifeMark's growth program. Under the terms of this funding, Alaris' distribution from LifeMark will increase by approximately $2.2 million on an annualized basis for a return of 18.2%. "Alaris is very pleased to be investing additional capital into LifeMark. LifeMark was our first investment, dating back nearly five years ago and has given us consistent and positive returns, particularly at a time when results from many other companies have been extremely volatile. LifeMark continues to prove themselves as one of the largest and best managed healthcare companies in Canada and we are looking forward to growing our relationship with them in the future," said Alaris President and CEO, Steve King. About the Corporation: Alaris provides alternative financing to private companies (throughout this press release, collectively identified as the "Private Company Partners" and individually as a "Private Company Partner") in exchange for royalties or distributions with the principal objective of generating stable and predictable cash flows for dividend payments to its shareholders. Royalties or distributions from the Private Company Partners are structured as a percentage of a "top line" financial performance measure such as gross margin and same-store sales and rank in priority to the owners' common equity position. Forward-Looking Statements This news release contains forward-looking statements and forward-looking information within the meaning of applicable Canadian securities legislation (collectively, "forward-looking statements"). Specifically, this press release contains forward-looking statements relating to the use of proceeds by LifeMark, the yield to be received by Alaris from the contribution to LifeMark and the expectations regarding the performance of LifeMark. The forward-looking statements are based on certain key expectations and assumptions made by Alaris, including, without limitation, assumptions concerning the use of proceeds and the yield to be received from the contribution to LifeMark, which expectations and assumptions management of Alaris believes to be reasonable at this time. Although Alaris believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable at the date of this press release, undue reliance should not be placed on the forward-looking statements and information as Alaris can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Additionally, the intended use of the proceeds of the Offering by Alaris may change if the board of directors of Alaris determines that it would be in the best interests of Alaris to deploy the proceeds for some other purpose. The forward-looking statements contained in this press release are made as of the date hereof and Alaris undertakes no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.
For more information please contact:Alaris Royalty Corp. Curtis Krawetz Manager, Investor Relations (403) 221-7305